Becton, Dickinson and Company (BD) is a global medical technology company that is focused on improving the lives of people around the world. The company was founded in 1897 and has grown to become a leader in the field of medical devices and diagnostic products, with a presence in more than 50 countries.
BD’s product portfolio includes a wide range of medical devices, including needles and syringes, IV catheters and administration sets, safety-engineered devices, and blood collection products. The company also offers a range of diagnostic products, including reagents, instruments, and software for laboratories, hospitals, and clinics.
One of BD’s key areas of focus is infection prevention and control. The company offers a range of products designed to reduce the risk of healthcare-associated infections, including hand hygiene products, personal protective equipment, and surface disinfectants.
In addition to its core medical technology business, BD also has a number of other businesses, including a global pharmacy services division and a life sciences research and development division.
BD is committed to sustainability and social responsibility, and has a number of initiatives in place to reduce its environmental impact and promote health and wellness in the communities in which it operates.
In conclusion, Becton, Dickinson and Company is a global medical technology company that is dedicated to improving the lives of people around the world through its innovative products and services. The company’s broad portfolio of medical devices and diagnostic products is helping to advance healthcare and reduce the risk of infection in hospitals and clinics around the world.
